Source: Eur Respir Mon; 2006: 38: 84–99
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E.G. Tzortzaki, N.M. Siafakas. Genetic susceptibility to chronic obstructive pulmonary disease. Eur Respir Mon; 2006: 38: 84–99

Member's Comments

No comment yet.

Related content which might interest you: Inflammation in COPD: a link to systemic comorbidities Source: Eur Respir Rev 2007; 16: 91-97 Year: 2007 Epidemiology of chronic obstructive pulmonary disease Source: Eur Respir J 2001; 17: 982-994 Year: 2001 Implications for disease and therapy Source: Annual Congress 2005 - Oxidative and nitrative stress: control of cell function in COPD Year: 2005 Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease Source: Eur Respir J 2004; 23: 629-636 Year: 2004 CTLA4 gene polymorphisms are associated with chronic bronchitis Source: Eur Respir J 2009; 34: 598 Year: 2009 Age-dependent systemic elastin degradation is enhanced in chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Expression of MIC-A in bronchial epithelium associates with cigarette smoking: a sign of induced autoimmune mechanisms? Source: Annual Congress 2005 - Lung structure: current concepts Year: 2005 Potential association between pulmonary hypertension in COPD and monocyte chemoattractant protein (MCP)-1 Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology Year: 2005 Effects of N-acetylcystein on oxidant-antioxidant activity in smokers with chronic obstructive pulmonary disease Source: Annual Congress 2005 - What's new in tobacco and lung disease Year: 2005 Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 325-331 Year: 2002 Identification of oxidative stress markers and their association with inflammation in smokers and early chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 The role of inflammation in COPD Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Proteinase 3 activity in sputum from subjects with alpha-1-antitrypsin deficiency and COPD Source: Eur Respir J 2013; 41: 1042-1050 Year: 2013 Tissue inhibitor of metalloproteinases-;2 gene polymorphisms in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 748-752 Year: 2001 Biomarkers in the management of COPD Source: Eur Respir Rev 2009; 18: 96-104 Year: 2009 Systemic effects of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 347-360 Year: 2003 Genetic risks in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 454s Year: 2003 Local and systemic inflammation in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Differences in microsatellite DNA level between asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: 472-478 Year: 2006 Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016